Geode Capital Management LLC trimmed its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 0.9% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,193,989 shares of the company's stock after selling 37,035 shares during the period. Geode Capital Management LLC owned about 2.46% of Option Care Health worth $131,295,000 as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in OPCH. Blue Trust Inc. raised its position in Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company's stock valued at $81,000 after buying an additional 377 shares during the period. GAMMA Investing LLC grew its stake in Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company's stock valued at $28,000 after purchasing an additional 471 shares in the last quarter. Lindenwold Advisors INC increased its position in Option Care Health by 5.4% in the 3rd quarter. Lindenwold Advisors INC now owns 9,548 shares of the company's stock worth $299,000 after purchasing an additional 489 shares during the last quarter. Trust Point Inc. raised its stake in shares of Option Care Health by 2.6% during the 3rd quarter. Trust Point Inc. now owns 24,124 shares of the company's stock worth $755,000 after purchasing an additional 622 shares in the last quarter. Finally, Orion Portfolio Solutions LLC lifted its holdings in shares of Option Care Health by 2.3% during the 3rd quarter. Orion Portfolio Solutions LLC now owns 28,232 shares of the company's stock valued at $884,000 after buying an additional 636 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.
Option Care Health Stock Down 0.2 %
OPCH traded down $0.04 during trading on Tuesday, reaching $23.42. The company had a trading volume of 2,857,817 shares, compared to its average volume of 1,569,037. The company has a market cap of $3.99 billion, a P/E ratio of 19.68, a PEG ratio of 2.45 and a beta of 1.33. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $34.63. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The business's fifty day moving average price is $25.20 and its 200 day moving average price is $28.37.
Insider Buying and Selling at Option Care Health
In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the business's stock in a transaction dated Friday, November 8th. The stock was purchased at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the transaction, the director now owns 326,334 shares in the company, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.64% of the company's stock.
Analyst Ratings Changes
Several research firms recently issued reports on OPCH. Barrington Research dropped their price target on shares of Option Care Health from $40.00 to $32.00 and set an "outperform" rating for the company in a research report on Thursday, October 31st. The Goldman Sachs Group cut shares of Option Care Health from a "buy" rating to a "neutral" rating and cut their target price for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Bank of America cut Option Care Health from a "buy" rating to a "neutral" rating and dropped their price target for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. JMP Securities boosted their price objective on Option Care Health from $36.00 to $37.00 and gave the stock a "market outperform" rating in a research note on Monday, September 30th. Finally, Jefferies Financial Group lowered Option Care Health from a "buy" rating to a "hold" rating and lowered their target price for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, Option Care Health presently has a consensus rating of "Hold" and an average target price of $30.14.
Get Our Latest Stock Report on Option Care Health
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
